TGFB1 and neoplasm: Many human tumors have upregulation of the Transforming growth factor β (TGF‐β) expression that promotes a therapy‐resistant phenotype which in turn creates epithelium plasticity and mesenchymal differentiation leading to an immunosuppressive tumor environment.